Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC

被引:0
|
作者
Spurr, L. F. [1 ]
Martinez, C. [1 ]
Kang, W. [1 ]
Chen, M. [1 ]
Zha, Y. [1 ]
Hseu, R. [1 ]
Gutiontov, S. [2 ]
Turchan, W. T. [1 ]
Lynch, C. [3 ]
Pointer, K. B. [4 ]
Vokes, E. E. [5 ]
Bestvina, C. M. [6 ]
Patel, J. D. [7 ]
Diehn, M. [8 ]
Weichselbaum, R. R. [9 ]
Chmura, S. J. [10 ]
Pitroda, S. P. [2 ]
机构
[1] Univ Chicago, Chicago, IL USA
[2] Univ Chicago, Dept Radiat & Cellular Oncol, Med Ctr, Chicago, IL USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[4] Univ Wisconsin, Madison, WI USA
[5] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL USA
[6] Univ Chicago, Dept Hematol Oncol, Med Ctr, Chicago, IL USA
[7] Northwestern Univ, Feinberg Sch Med, Lurie Canc Ctr, Chicago, IL USA
[8] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA USA
[9] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[10] Univ N Carolina, Dept Med, Chapel Hill, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
137
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [11] LOCAL BUT NOT SYSTEMIC TEMOZOLOMIDE COMBINED WITH IMMUNOTHERAPY IMPROVES THE SURVIVAL IN AN EXPERIMENTAL GLIOMA MODEL
    Fritzell, Sara
    Eberstal, Sofia
    Sanden, Emma
    Visse, Edward
    Darabi, Anna
    Siesjo, Peter
    NEURO-ONCOLOGY, 2012, 14 : 61 - 62
  • [12] Adaptive radiation strategy with V20 limitation associates with survival benefit and lower incidence of symptomatic radiation pneumonitis in stage III NSCLC patients receiving concurrent immunotherapy and thoracic radiation
    Song, Zewen
    Zhang, Xi
    Ma, Yechen
    Ma, Shuyun
    Feng, Ziyang
    Liu, Xuewen
    TRANSLATIONAL ONCOLOGY, 2025, 51
  • [13] Immunotherapy in Combination with Surgery and Radiation Improves Local Control for Primary Mucosal Melanomas
    Westergaard, S. A.
    Abugideiri, M.
    Switchenko, J.
    Khan, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E5 - E5
  • [14] RFA COMBINED WITH RADIATION OR CHEMOTHERAPY IMPROVES SURVIVAL OF INOPERABLE NSCLC PATIENTS - BANGLADESHI EXPERIENCES
    Hassan, Mohammad R.
    Murshed, Sarwar
    RESPIROLOGY, 2010, 15 : 36 - 36
  • [15] Radiation therapy reduces local failure and improves overall survival in sPNET
    Spalding, Aaron C.
    Hamstra, Daniel A.
    PEDIATRIC BLOOD & CANCER, 2008, 51 (01) : 148 - 148
  • [16] Immunotherapy combined with local Treatment improves the Overall Survival of Melanoma Patients with Brain Metastases
    Tampouri, I
    Amaral, T.
    Eigentler, T.
    Keim, U.
    Lomberg, D.
    Klumpp, B.
    Heinrich, V
    Zips, D.
    Paulsen, F.
    Gepfner-Tuma, I
    Skardelly, M.
    Tatagiba, M.
    Tabatabai, G.
    Garbe, C.
    Forschner, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 56 - 56
  • [17] Prognostic factors for survival in locally advanced NSCLC treated with concurrent chemo- radiation: An institutional analysis.
    Medavaram, Sowmini
    Sher, Amna Falak
    Nemesure, Barbara
    Keresztes, Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [18] Recombinant Human Endostatin (Endostar) Combined with Concurrent Intensity Modulated Radiation Therapy for Elderly Local Advanced NSCLC
    Chen, Q.
    Xie, Q.
    Shi, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2178 - S2178
  • [19] Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy
    Wang, Yu
    Wang, Wenqing
    Zhang, Tao
    Yang, Yin
    Wang, Jianyang
    Li, Canjun
    Xu, Xin
    Wu, Yuqi
    Jiang, Ying
    Duan, Jinghao
    Wang, Luhua
    Bi, Nan
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (02): : 177 - 187
  • [20] Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)
    Cardona, A. F.
    Ruiz-Patino, A.
    Arrieta, O. G.
    Martin, C.
    Raez, L.
    Zatarain Barron, Z. L.
    Barron, F.
    Ricaurte, L.
    Bravo-Garzon, M. A.
    Mas, L.
    Corrales, L.
    Rojas, L. L.
    Lupinacci, L.
    Perazzo, F.
    Bas, C.
    Carranza, O.
    Puparelli, C.
    Rizzo, M.
    Ruiz, R.
    Rolfo, C.
    Archila, P.
    Rodriguez, J.
    Sotelo, C.
    Vargas, C.
    Carranza, H.
    Otero, J.
    Pino, L.
    Ortiz, C.
    Laguado, P.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S984 - S985